CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.150

+2.7%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A.J. Mullen who wrote (27)	2/15/1997 1:49:00 AM
From: Larry Liebman	of 668

So with CBMI sliding towards $11, I called the company and talked to one of the Doc's...His assessment was the following...First, the primary endpoint of the trial was to establish equivalency- which the initial results appear to confirm...Second, and what he stressed was the following: Which procedure would a client/physician/H.M.O. choose (a) Undergo an initial surgery which removes bone chips from your hip, which results in significant blood loss, pain, and a 25% risk of infection and then have a second surgical procedure to do the grafting OR (2) use 0P-1 in a single procedure to treat a non-union fracture...In the pharmo-economic world of the 90's OP-1 would be the treatment of choice...As an aside, he added as I was about to get back to work, both Cowen and H&Q reiterated "strong buy" recommendations today following a review of the data released at the AAOS yesterday...CBMI rebounded nicely from the early lows..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next